Alivus Life Sciences Ltd.

BSE: 543322 | NSE: ALIVUS

Small Cap | Pharmaceuticals & Drugs

900.20

10.60 (1.19%)

< Home < Back

Glenmark Life Sciences informs about board meeting

Date: 08-11-2021

Glenmark Life Sciences has informed that the Board of Directors of the Company at its meeting scheduled to be held on Wednesday, November 10, 2021 will also consider proposal for payment of interim Dividend to members of the Company for the Financial year 2021-22.

The above information is a part of company’s filings submitted to BSE.